Factor V Leiden mutation and type 1 diabetes mellitus

Blood Coagulation and Fibrinolysis

Volumn 19, Issue 1, 2008, Pages 70-74

  Demirer, Asli Nar ^a   Alikasifoglu, Mehmet ^b   Tuncbilek, Ergul ^b   Karakus, Sema ^a   Erbas, Tomris ^b  

^a BASKENT UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Activated protein C sensitivity ratio; Factor V Leiden mutation; Thrombophilia; Type 1 diabetes mellitus

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; POINT MUTATION; POLYMERASE CHAIN REACTION; POPULATION; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; THROMBOSIS; VEIN THROMBOSIS;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; FACTOR V; FEMALE; HUMANS; MALE;

EID: 37849022695     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3282f38c5f     Document Type: Article

References (33)

1. Colwell JA. Vascular thrombosis in type 2 diabetes mellitus. Diabetes 1993; 42:8-11.
2. Carr ME. Diabetes mellitus: a hypercoagulable state. J Diabetes Complications 2001; 15:44-54.
3. Fuller JH, Keen H, Jarrett RJ, Omer T. Haemostatic variables associated with diabetes and its complications. BMJ 1979; 2:964-966.
4. Aso Y, Matsumoto S, Fujiwara Y, Tayama K, Inukai T, Takemura Y. Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1. Metabolism 2002; 51:471-476.
5. Sobel BE, Schneider DJ. Platelet function, coagulopathy, and impaired fibrinolysis in diabetes. Cardiol Clin 2004; 22:511-526.
6. Prandoni P. Links between arterial and venous disease. J Intern Med 2007; 262:341-350.
7. Petrauskiene V, Falk M, Waernbaum I, Norberg M, Eriksson JW. The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia 2005; 48:1017-1021.
8. Hong C, Zhu F, Du D, Pilgram TK, Sicard GA, Bae KT. Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism. Atherosclerosis 2005; 183:169-174.
9. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence. Arch Intern Med 2002; 162:1182-1189.
10. Ageno W, Prandoni P, Romualdi E, Ghirarduzzi A, Dentali F, Pesavento R, et al. The metabolic syndrome and the risk of venous thrombosis. A prospective, case control study. J Thromb Haemost 2006; 4:1914-1918.
11. Gruden G, Olivetti C, Cavallo-Perin P, Bazzan M, Stella S, Tamponi G, Pagano G. Activated protein C resistance in type 1 diabetes. Diabetes Care 1997; 20:424-425.
12. Odawara M, Yamashita K. Activated protein C resistance and Japanese NIDDM patients with coronary heart disease (Letter). Diabetes Care 1997; 20:1339.
13. Dahlbäck B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci U S A 1994; 91:1396-1400.
14. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64-67.
15. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346:1133-1134.
16. Dahlbäck B. Molecular genetics of thrombophilia: factor V gene mutation causing resistance to activated protein C as a basis of the hypercoagulable state. J Lab Clin Med 1995; 125:566-571.
17. Hillarp A, Zöller B, Dahlbäck B. Activated protein C resistance as a basis for venous thrombosis. Am J Med 1996; 101:534-540.
18. Krekora K, De Lucia D, Capani F, Donati MB, Iacoviello L. Association of coagulation factor V (Arg506Gln) mutation with noninsulin-dependent diabetes mellitus. Lancet 1996; 348:1666-1667.
19. Odawara M, Yamashita K. Factor V Leiden mutation and Japanese noninsulin-dependent diabetes mellitus. Diabetologia 1997; 40:1363-1364.
20. Matsuda T, Morishita E, Jokaji H, Asakura H, Saito M, Yoshida T, Takemoto K. Mechanism on disorders of coagulation and fibrinolysis in diabetes. Diabetes 1996; 45 (Suppl. 3):S109-S110.
21. Foley PW, Irvine CD, Standen GR, Morse C. Activated protein C, factor V Leiden and peripheral vascular disease. Cardiovasc Surg 1997; 5:157-160.
22. Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, Danesh J. Seven haemostatic gene polymorphisms in coronary disease: metaanalysis of 66,155 cases and 91,307 controls. Lancet 2006; 367:651-658.
23. de Moerloose P, Boehlen F. Inherited thrombophilia in arterial disease: a selective review. Semin Hematol 2007; 44:106-113.
24. Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AW, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003; 348:1435-1441.
25. Bova C, Marchiori A, Noto A, Rossi V, Daniele F, Santoro C, et al. Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. A retrospective cohort study. Thromb Haemost 2006; 96:132-136.
26. Gabazza EC, Takeya H, Deguchi H, Sumida Y, Taguchi O, Murata K, et al. Protein C activation in NIDDM patients. Diabetologia 1996; 39:1455-1461.
27. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332:912-917.
28. Dahlbäck B, Hillarp A, Rosen S, Zoller B. Resistance to activated protein C, the FV:Q506 allele and venous thrombosis. Ann Hematol 1996; 72:166-176.
29. Maser RE, Miele ME, Lenhard MJ, DeCherney SG, McNicholas KW, Serra AJ, Lemole GM. Lack of association of factor V Leiden and coronary heart disease in individuals with and without diabetes. Diabetes Care 1998; 21:198.
30. Wakim-Ghorayeb SF, Keleshian SH, Timson G, Finan RR, Najm P, Irani-Hakime N, Almawi WY. Factor V G1691A (Leiden) and prothrombin G20210A single-nucleotide polymorphisms in type 2 diabetes mellitus. Am J Hematol 2005; 80:84-86.
31. Worly JM, Fortenberry JD, Hansen I, Chambliss CR, Stockwell J. Deep venous thrombosis in children with diabetic ketoacidosis and femoral central venous catheters. Pediatrics 2004; 113:e57-e60.
32. Rosenbloom AL. Fatal cerebral infarctions in diabetic ketoacidosis in a child with previously unknown heterozygosity for factor V Leiden deficiency. J Pediatr 2004; 145:561-562.
33. Haller MJ, Valladares A, Rosenbloom AL. Arterial thrombosis resulting in amputation in a child with poorly controlled type 1 diabetes and heterozygous Factor V Leiden mutation. Pediatr Diabetes 2006; 7:229-231.